A Site and Subject Blinded Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS 852927 in Patients With Primary Hypercholesterolemia on a Stable Dose of Statin Therapy

Trial Profile

A Site and Subject Blinded Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS 852927 in Patients With Primary Hypercholesterolemia on a Stable Dose of Statin Therapy

Discontinued
Phase of Trial: Phase I

Latest Information Update: 02 Aug 2013

At a glance

  • Drugs BMS 852927 (Primary) ; HMG-CoA reductase inhibitors
  • Indications Hypercholesterolaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Jun 2013 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 01 Aug 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top